These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 25711400)

  • 1. Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies.
    Lipshultz LI; Goldstein I; Seftel AD; Kaufman GJ; Smith TM; Tursi JP; Burnett AL
    BJU Int; 2015 Oct; 116(4):650-6. PubMed ID: 25711400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
    Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
    J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.
    Cocci A; Russo GI; Salonia A; Cito G; Regis F; Polloni G; Giubilei G; Cacciamani G; Capece M; Falcone M; Greco I; Timpano M; Minervini A; Gacci M; Cai T; Garaffa G; Giammusso B; Arcaniolo D; Mirone V; Mondaini N
    J Sex Med; 2018 May; 15(5):716-721. PubMed ID: 29699756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
    Levine LA; Larsen SM
    J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
    Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
    J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD).
    Carson CC; Sadeghi-Nejad H; Tursi JP; Smith TM; Kaufman GJ; Gilbert K; Honig SC
    BJU Int; 2015 Nov; 116(5):815-22. PubMed ID: 25818264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie's Disease, Subgrouped by Penile Plaque Calcification.
    Goldstein I; McLane MP; Xiang Q; Wolfe HR; Hu Y; Gelbard MK
    Urology; 2020 Dec; 146():145-151. PubMed ID: 32896582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.
    Abdel Raheem A; Capece M; Kalejaiye O; Abdel-Raheem T; Falcone M; Johnson M; Ralph OG; Garaffa G; Christopher AN; Ralph DJ
    BJU Int; 2017 Nov; 120(5):717-723. PubMed ID: 28612401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
    Ralph DJ; Abdel Raheem A; Liu G
    J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.
    Dhillon S
    Drugs; 2015 Aug; 75(12):1405-12. PubMed ID: 26201462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Men With Peyronie's Disease and Collagenase Clostridium Histolyticum Treatment Failure: Predictors of Surgical Intervention and Outcomes.
    Bajic P; Wiggins AB; Ziegelmann MJ; Levine LA
    J Sex Med; 2020 May; 17(5):1005-1011. PubMed ID: 32127330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact.
    Gabrielson AT; Spitz JT; Hellstrom WJG
    Sex Med Rev; 2018 Jan; 6(1):143-156. PubMed ID: 28454897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies.
    Hellstrom WJ; Feldman RA; Coyne KS; Kaufman GJ; Smith TM; Tursi JP; Rosen RC
    Urology; 2015 Aug; 86(2):291-8. PubMed ID: 26199168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Curvature Improvement in Men With Peyronie's Disease Treated With Intralesional Collagenase Clostridium Histolyticum.
    Flores JM; Nascimento B; Punjani N; Salter CA; Bernie HL; Taniguchi H; Miranda E; Terrier JE; Schofield E; Jenkins L; Mulhall JP
    J Sex Med; 2022 Nov; 19(11):1680-1686. PubMed ID: 36127227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute-Phase Peyronie's Disease.
    Nguyen HMT; Anaissie J; DeLay KJ; Yafi FA; Sikka SC; Hellstrom WJG
    J Sex Med; 2017 Oct; 14(10):1220-1225. PubMed ID: 28874331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenase Clostridium histolyticum Treatment Improves Degree of Curvature in Peyronie's Disease with Calcified Plaques.
    Masterson TA; Atuluru P; Zucker I; Molina M; Ibrahim E; Nackeeran S; Kava B; Ramasamy R
    Eur Urol Focus; 2023 Jan; 9(1):55-59. PubMed ID: 36272924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study.
    Cocci A; Russo GI; Briganti A; Salonia A; Cacciamani G; Capece M; Falcone M; Timpano M; Cito G; Verze P; Giammusso B; Morgia G; Mirone V; Minervini A; Gacci M; Cai T; Serni S; Carini M; Giubilei G; Mondaini N
    BJU Int; 2018 Oct; 122(4):680-687. PubMed ID: 29791971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.
    Gelbard M; Hellstrom WJ; McMahon CG; Levine LA; Smith T; Tursi J; Kaufman G; Goldstein I
    J Sex Med; 2013 Nov; 10(11):2822-31. PubMed ID: 24112401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety Profile of Collagenase Clostridium Histolyticum Stratified by Degree of Penile Curvature in Patients With Peyronie Disease.
    Hellstrom WJG; Tan RBW; Liu G
    Urology; 2017 Aug; 106():237.e9-237.e14. PubMed ID: 28502596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
    Goldstein I; Lipshultz LI; McLane M; Hu Y; Xiang Q; Liu G; Vijayan S; Gelbard MK
    J Urol; 2020 Jun; 203(6):1191-1197. PubMed ID: 31922462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.